Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and Adenocarcinoma

1,2-distearoylphosphatidylethanolamine has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evjen, TJ; Fossheim, SL; Hagtvet, E; Nilssen, EA; Olsen, DR1
Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A1

Other Studies

2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Adenocarcinoma

ArticleYear
Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice.
    Journal of drug targeting, 2011, Volume: 19, Issue:8

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Carriers; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phonophoresis; Phosphatidylethanolamines; Prostatic Neoplasms; Tissue Distribution; Xenograft Model Antitumor Assays

2011
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
    Nuclear medicine communications, 1999, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured

1999